DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

169 hedge funds and large institutions have $1.27B invested in Dicerna Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 50 increasing their positions, 40 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
169
Holders Change
+57
Holders Change %
+50.89%
% of All Funds
3.34%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.08%
New
67
Increased
50
Reduced
40
Closed
9
Calls
$1.98M
Puts
$2.65M
Net Calls
-$667K
Net Calls Change
-$880K

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$72.3M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$27.8M
3
DCM
3
Driehaus Capital Management
Illinois
$21.9M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$21.6M
5
ACM
5
Aquilo Capital Management
California
$13.5M

Top Sellers

1
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$89.9M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$8.81M
3
RCM
3
RA Capital Management
Massachusetts
$0
4
BI
4
BVF Inc
California
$0
5
BM
5
Bridger Management
New York
$43.7M
Name Holding Trade Value Shares
Change 		Shares
Change %
JPMorgan Chase & Co
26
JPMorgan Chase & Co
New York
$12.4M +$2.15M +97,622 +21%
Two Sigma Investments
27
Two Sigma Investments
New York
$12.3M +$12.3M +557,607 New
AG
28
Artal Group
Luxembourg
$11M -$11M -500,000 -50%
Two Sigma Advisers
29
Two Sigma Advisers
New York
$9.71M +$7.68M +348,600 +379%
Adage Capital Partners
30
Adage Capital Partners
Massachusetts
$8.81M -$47.4M -2,150,000 -84%
Nuveen Asset Management
31
Nuveen Asset Management
Illinois
$8.62M +$1.94M +88,054 +29%
ACP
32
Acuta Capital Partners
California
$8.54M +$8.54M +387,500 New
WP
33
Woodline Partners
California
$8.19M +$8.19M +371,868 New
Carson Wealth (CWM LLC)
34
Carson Wealth (CWM LLC)
Nebraska
$8.08M – – –
Federated Hermes
35
Federated Hermes
Pennsylvania
$7.99M +$5.04M +228,929 +171%
PAI
36
Palo Alto Investors
California
$7.31M – – –
Charles Schwab
37
Charles Schwab
California
$7.11M -$571K -25,930 -7%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$6.44M +$1.8M +81,638 +39%
Wellington Management Group
39
Wellington Management Group
Massachusetts
$5.9M +$5.9M +267,824 New
PHP
40
Parkman Healthcare Partners
Connecticut
$5.29M +$5.29M +240,000 New
VOYA Investment Management
41
VOYA Investment Management
Georgia
$4.76M +$4.27M +193,681 +870%
MWNA
42
Marshall Wace North America
New York
$4.67M +$4.65M +211,274 +41,024%
IHAM
43
Integral Health Asset Management
New York
$4.41M +$4.41M +200,000 New
Arrowstreet Capital
44
Arrowstreet Capital
Massachusetts
$4.4M +$4.4M +199,801 New
Connor, Clark & Lunn Investment Management (CC&L)
45
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$4.09M +$4.09M +185,850 New
EI
46
EAM Investors
California
$3.77M +$3.77M +171,088 New
Allianz Asset Management
47
Allianz Asset Management
Germany
$3.75M -$807K -36,627 -18%
WG
48
Winton Group
United Kingdom
$3.54M +$2.76M +125,297 +356%
SI
49
Sofinnova Investments
California
$3.51M -$4.04M -183,243 -53%
Morgan Stanley
50
Morgan Stanley
New York
$3.35M +$2.92M +132,568 +688%
1
2
3 4 5